Phio Pharmaceuticals (United States)

Phio Pharmaceuticals (United States)

Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Phio Pharmaceuticals (United States), United States, covering academic research published from 2009 to 2023. Read More.


Open Access Percentage

59%


Total
Publications

51


Total Open
Publications

30


Total
Citations

539


Open Access
Percentage

59%


Total
Publications

51


Total Open
Publications

30


Total
Citations

539

Wikipedia

Website

download

Breakdown

45% 12% 2% 41%

Publisher Open

45%

Both

12%

Other Platform Open

2%

Closed

41%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0123456789101112Total Publications
200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

14%OA Journal

OA Journal 14%

4

Hybrid 45%

13

No Guarantees 41%

12

Other Platform Open

Domain 100%

7

Institution 14%

1

Preprint 0%

0

Public 0%

0

Other Internet 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
7
Europe PMC
Domain
5
University of Massachusetts Medical School - eScholarship@UMMS
Institution
2
1 / 1

Data updated 25 January 2024

Share

Share

Share